Rationale for intensive intravesical chemotherapy for superficial bladder cancer

M. S. Soloway

doi:10.1016/S0022-5347(17)55976-5

Rationale for intensive intravesical chemotherapy for superficial bladder cancer

M. S. Soloway

Urology

Research output: Contribution to journal › Review article

101 Scopus citations

Abstract

The high incidence of vesical tumors after initial management of a superficial tumor (stages 0 and A) presents a major therapeutic challenge to the urologist. This incidence of subsequent tumors ranges from 40 to 70 per cent and is consistent among several series. Most of these tumors will occur within 6 to 12 months. I herein review some factors accounting for this high incidence and suggest a therapeutic strategy that might delay or prevent these rapid recurrences.

Original language	English (US)
Pages (from-to)	461-466
Number of pages	6
Journal	Journal of Urology
Volume	123
Issue number	4
DOIs	https://doi.org/10.1016/S0022-5347(17)55976-5
State	Published - Jan 1 1980

ASJC Scopus subject areas

Urology

Access to Document

10.1016/S0022-5347(17)55976-5

Fingerprint Dive into the research topics of 'Rationale for intensive intravesical chemotherapy for superficial bladder cancer'. Together they form a unique fingerprint.

Cite this

Soloway, M. S. (1980). Rationale for intensive intravesical chemotherapy for superficial bladder cancer. Journal of Urology, 123(4), 461-466. https://doi.org/10.1016/S0022-5347(17)55976-5

@article{72d0d28c26e84540905b37abdc58bcba,

title = "Rationale for intensive intravesical chemotherapy for superficial bladder cancer",

abstract = "The high incidence of vesical tumors after initial management of a superficial tumor (stages 0 and A) presents a major therapeutic challenge to the urologist. This incidence of subsequent tumors ranges from 40 to 70 per cent and is consistent among several series. Most of these tumors will occur within 6 to 12 months. I herein review some factors accounting for this high incidence and suggest a therapeutic strategy that might delay or prevent these rapid recurrences.",

author = "Soloway, {M. S.}",

year = "1980",

month = jan,

day = "1",

doi = "10.1016/S0022-5347(17)55976-5",

language = "English (US)",

volume = "123",

pages = "461--466",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Rationale for intensive intravesical chemotherapy for superficial bladder cancer

AU - Soloway, M. S.

PY - 1980/1/1

Y1 - 1980/1/1

N2 - The high incidence of vesical tumors after initial management of a superficial tumor (stages 0 and A) presents a major therapeutic challenge to the urologist. This incidence of subsequent tumors ranges from 40 to 70 per cent and is consistent among several series. Most of these tumors will occur within 6 to 12 months. I herein review some factors accounting for this high incidence and suggest a therapeutic strategy that might delay or prevent these rapid recurrences.

AB - The high incidence of vesical tumors after initial management of a superficial tumor (stages 0 and A) presents a major therapeutic challenge to the urologist. This incidence of subsequent tumors ranges from 40 to 70 per cent and is consistent among several series. Most of these tumors will occur within 6 to 12 months. I herein review some factors accounting for this high incidence and suggest a therapeutic strategy that might delay or prevent these rapid recurrences.

UR - http://www.scopus.com/inward/record.url?scp=0018826157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018826157&partnerID=8YFLogxK

U2 - 10.1016/S0022-5347(17)55976-5

DO - 10.1016/S0022-5347(17)55976-5

M3 - Review article

C2 - 6767860

AN - SCOPUS:0018826157

VL - 123

SP - 461

EP - 466

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 4

ER -